BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hussman JP. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention. Front Pharmacol. 2020;11:1169. [PMID: 32848776 DOI: 10.3389/fphar.2020.01169] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 El-Solh AA, Meduri UG, Lawson Y, Carter M, Mergenhagen KA. Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository.J Intensive Care Med. 2021;36:664-672. [PMID: 33685275 DOI: 10.1177/0885066621994476] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Tamimi F, Altigani S, Sanz M. Periodontitis and coronavirus disease 2019. Periodontol 2000 2022. [PMID: 35244975 DOI: 10.1111/prd.12434] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang B, Zuo X, Peng L, Wang X, Zeng H, Zhong J, Li S, Xiao Y, Wang L, Ouyang H, Yuan J. Melatonin ameliorates oxidative stress-mediated injuries through induction of HO-1 and restores autophagic flux in dry eye. Exp Eye Res 2021;205:108491. [PMID: 33587908 DOI: 10.1016/j.exer.2021.108491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Brance ML, Cóccaro NM, Casalongue AN, Durán A, Brun LR. Extensive progressive heterotopic ossification post-Covid-19 in a man. Bone 2022;155:116287. [PMID: 34896358 DOI: 10.1016/j.bone.2021.116287] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol 2021;12:598925. [PMID: 33716737 DOI: 10.3389/fphar.2021.598925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jevnikar K, Jaki Mekjavic P, Vidovic Valentincic N, Petrovski G, Globocnik Petrovic M. An Update on COVID-19 Related Ophthalmic Manifestations. Ocul Immunol Inflamm 2021;:1-6. [PMID: 33826465 DOI: 10.1080/09273948.2021.1896008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. The Role of Alveolar Edema in COVID-19. Cells 2021;10:1897. [PMID: 34440665 DOI: 10.3390/cells10081897] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021;12:658519. [PMID: 34276652 DOI: 10.3389/fimmu.2021.658519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alfarouk KO, AlHoufie STS, Ahmed SBM, Shabana M, Ahmed A, Alqahtani SS, Alqahtani AS, Alqahtani AM, Ramadan AM, Ahmed ME, Ali HS, Bashir A, Devesa J, Cardone RA, Ibrahim ME, Schwartz L, Reshkin SJ. Pathogenesis and Management of COVID-19. J Xenobiot 2021;11:77-93. [PMID: 34063739 DOI: 10.3390/jox11020006] [Reference Citation Analysis]
11 Janiuk K, Jabłońska E, Garley M. Significance of NETs Formation in COVID-19. Cells 2021;10:151. [PMID: 33466589 DOI: 10.3390/cells10010151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
12 Rhoades R, Solomon S, Johnson C, Teng S. Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders. Front Microbiol 2022;13:845559. [PMID: 35444632 DOI: 10.3389/fmicb.2022.845559] [Reference Citation Analysis]
13 Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells 2021;10:1993. [PMID: 34440767 DOI: 10.3390/cells10081993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gillot C, Favresse J, Mullier F, Lecompte T, Dogné JM, Douxfils J. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Front Pharmacol 2021;12:708302. [PMID: 34421600 DOI: 10.3389/fphar.2021.708302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cardoso EOC, Fine N, Glogauer M, Johnson F, Goldberg M, Golub LM, Tenenbaum HC. The Advent of COVID-19; Periodontal Research Has Identified Therapeutic Targets for Severe Respiratory Disease; an Example of Parallel Biomedical Research Agendas. Front Dent Med 2021;2:674056. [DOI: 10.3389/fdmed.2021.674056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Huang YK, Li YJ, Li B, Wang P, Wang QH. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives. World J Gastroenterol 2021; 27(27): 4358-4370 [PMID: 34366609 DOI: 10.3748/wjg.v27.i27.4358] [Reference Citation Analysis]
17 Trovato CM, Montuori M, Pietropaoli N, Oliva S. COVID-19 and celiac disease: A pathogenetic hypothesis for a celiac outbreak. Int J Clin Pract 2021;75:e14452. [PMID: 34145702 DOI: 10.1111/ijcp.14452] [Reference Citation Analysis]
18 Sonzogni-Desautels K, Ndao M. Will Auranofin Become a Golden New Treatment Against COVID-19? Front Immunol 2021;12:683694. [PMID: 34630379 DOI: 10.3389/fimmu.2021.683694] [Reference Citation Analysis]
19 Babalola OE, Bode CO, Ajayi AA, Alakaloko FM, Akase IE, Otrofanowei E, Salu OB, Adeyemo WL, Ademuyiwa AO, Omilabu S. Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double-blind, dose-response study in Lagos. QJM 2021:hcab035. [PMID: 33599247 DOI: 10.1093/qjmed/hcab035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
20 Purwati, Budiono, Rachman BE, Yulistiani, Miatmoko A, Nasronudin, Lardo S, Purnama YI, Laely M, Rochmad I, Ismail T, Wulandari S, Setyawan D, Rosyid AN, Setiawan HW, Wulaningrum PA, Asmarawati TP, Marfiani E, Yuniati SK, Fuadi MR, Endraswari PD, Purwaningsih, Hendrianto E, Karsari D, Dinaryanti A, Ertanti N, Ihsan IS, Purnama DS, Indrayani Y. A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections. Biochem Res Int 2021;2021:6685921. [PMID: 33628506 DOI: 10.1155/2021/6685921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines 2021;9:1688. [PMID: 34829918 DOI: 10.3390/biomedicines9111688] [Reference Citation Analysis]
22 Ansariniya H, Seifati SM, Zaker E, Zare F. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development. Biomed Res Int 2021;2021:8870425. [PMID: 33564683 DOI: 10.1155/2021/8870425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zhu Y, Chen X, Liu X. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond. Front Immunol 2022;13:838011. [PMID: 35309344 DOI: 10.3389/fimmu.2022.838011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
24 Perfetto L, Micarelli E, Iannuccelli M, Lo Surdo P, Giuliani G, Latini S, Pugliese GM, Massacci G, Vumbaca S, Riccio F, Fuoco C, Paoluzi S, Castagnoli L, Cesareni G, Licata L, Sacco F. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection. Genes (Basel) 2021;12:450. [PMID: 33809949 DOI: 10.3390/genes12030450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Alexaki VI, Henneicke H. The Role of Glucocorticoids in the Management of COVID-19. Horm Metab Res 2021;53:9-15. [PMID: 33207372 DOI: 10.1055/a-1300-2550] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Adibzadeh S, Amiri S, Nia GE, Taleghani MR, Bijarpas ZK, Maserat N, Maali A, Azad M, Behzad-Behbahani A. Therapeutic approaches and vaccination in fighting COVID-19 infections: A review. Gene Rep 2022;:101619. [PMID: 35530725 DOI: 10.1016/j.genrep.2022.101619] [Reference Citation Analysis]
27 Lartey NL, Valle-Reyes S, Vargas-Robles H, Jiménez-Camacho KE, Guerrero-Fonseca IM, Castellanos-Martínez R, Montoya-García A, García-Cordero J, Cedillo-Barrón L, Nava P, Filisola-Villaseñor JG, Roa-Velázquez D, Zavala-Vargas DI, Morales-Ríos E, Salinas-Lara C, Vadillo E, Schnoor M. ADAM17/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID-19. J Leukoc Biol 2021. [PMID: 34826347 DOI: 10.1002/JLB.3COVA0421-195RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, Entezari S, Ansari A, Poudineh M, Deravi N. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci 2022;9:804109. [DOI: 10.3389/fmolb.2022.804109] [Reference Citation Analysis]
29 Kelesidis T, Madhav S, Petcherski A, Cristelle H, O'Connor E, Hultgren NW, Ritou E, Williams DS, Shirihai OS, Reddy ST. The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells. Virulence 2021;12:2214-27. [PMID: 34494942 DOI: 10.1080/21505594.2021.1964329] [Reference Citation Analysis]
30 Tindle C, Fuller M, Fonseca A, Taheri S, Ibeawuchi SR, Beutler N, Claire A, Castillo V, Hernandez M, Russo H, Duran J, Crotty Alexander LE, Tipps A, Lin G, Thistlethwaite PA, Chattopadhyay R, Rogers TF, Sahoo D, Ghosh P, Das S. Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19. bioRxiv. 2020;2020:; 344002. [PMID: 33106807 DOI: 10.1101/2020.10.17.344002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
31 Schwarz P, Bidaud AL, Dannaoui E. In vitro synergy of isavuconazole in combination with colistin against Candida auris. Sci Rep 2020;10:21448. [PMID: 33293607 DOI: 10.1038/s41598-020-78588-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
32 Hamzagic AR, Miloradovic D, Miloradovic D, Ivosevic Z, Ljujic B. Mesenchymal Stem Cells Versus Covid-19. Can They Win the Battle? Serbian Journal of Experimental and Clinical Research 2021;0. [DOI: 10.2478/sjecr-2021-0024] [Reference Citation Analysis]
33 Singh B, Mal G, Verma V, Tiwari R, Khan MI, Mohapatra RK, Mitra S, Alyami SA, Emran TB, Dhama K, Moni MA. Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era. Stem Cell Res Ther 2021;12:283. [PMID: 33980321 DOI: 10.1186/s13287-021-02334-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Abramenko N, Vellieux F, Tesařová P, Kejík Z, Kaplánek R, Lacina L, Dvořánková B, Rösel D, Brábek J, Tesař A, Jakubek M, Smetana K Jr. Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences. Int J Mol Sci 2021;22:6551. [PMID: 34207220 DOI: 10.3390/ijms22126551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Li X, Xuan W, Chen D, Gao H, Wang G, Guo Q, Wang Y, Song H, Cai B. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis. J Alzheimers Dis 2020;78:1315-38. [PMID: 33164932 DOI: 10.3233/JAD-200770] [Reference Citation Analysis]
36 Aziz A, Choudhari R, Alexander AJ, Allam E. Heterotopic ossification post COVID-19: Report of two cases. Radiol Case Rep 2021;16:404-9. [PMID: 33354272 DOI: 10.1016/j.radcr.2020.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Khan N, Chen X, Geiger JD. Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments. Front Pharmacol 2020;11:595888. [PMID: 33324224 DOI: 10.3389/fphar.2020.595888] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
38 Hussman JP. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease. Front Med (Lausanne) 2021;8:637642. [PMID: 34239884 DOI: 10.3389/fmed.2021.637642] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Khan SA, Goliwas KF, Deshane JS. Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage. Front Physiol 2021;12:760638. [PMID: 34690821 DOI: 10.3389/fphys.2021.760638] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wahid B, Rani N, Idrees M. Cytokine storm syndrome in SARS-CoV-2: a review. Z Naturforsch C J Biosci 2021. [PMID: 34428364 DOI: 10.1515/znc-2021-0062] [Reference Citation Analysis]
41 Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ 2021;374:n1648. [PMID: 34312178 DOI: 10.1136/bmj.n1648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
42 Alfredo CA, Noemí CR, Samuel RL, Daniel OC, Rodrigo RB, Paul MT, Mónica ET, José CB, Eleazar LP, Alfonso AR, Luis CJ, Cindy B. Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study. Pharmaceuticals (Basel) 2022;15:757. [PMID: 35745676 DOI: 10.3390/ph15060757] [Reference Citation Analysis]
43 Tanwar O, Soni A, Prajapat P, Shivhare T, Pandey P, Samaiya PK, Pandey SP, Kar P. Ethyl Pyruvate as a Potential Defense Intervention against Cytokine Storm in COVID-19? ACS Omega 2021;6:7754-60. [PMID: 33778286 DOI: 10.1021/acsomega.1c00157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ramos E, López-Muñoz F, Gil-Martín E, Egea J, Álvarez-Merz I, Painuli S, Semwal P, Martins N, Hernández-Guijo JM, Romero A. The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants (Basel) 2021;10:1152. [PMID: 34356384 DOI: 10.3390/antiox10071152] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Tindle C, Fuller M, Fonseca A, Taheri S, Ibeawuchi SR, Beutler N, Katkar GD, Claire A, Castillo V, Hernandez M, Russo H, Duran J, Crotty Alexander LE, Tipps A, Lin G, Thistlethwaite PA, Chattopadhyay R, Rogers TF, Sahoo D, Ghosh P, Das S. Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19. Elife 2021;10:e66417. [PMID: 34463615 DOI: 10.7554/eLife.66417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Abidi E, El Nekidy WS, Alefishat E, Rahman N, Petroianu GA, El-lababidi R, Mallat J. Tocilizumab and COVID-19: Timing of Administration and Efficacy. Front Pharmacol 2022;13:825749. [DOI: 10.3389/fphar.2022.825749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
47 Örs ED, Alkan ŞB, Öksüz A. Possible Effect of Astaxanthin on Obesity-related Increased COVID-19 Infection Morbidity and Mortality. CNF 2022;18:265-73. [DOI: 10.2174/1573401317666211011105732] [Reference Citation Analysis]
48 Witika BA, Makoni PA, Mweetwa LL, Ntemi PV, Chikukwa MTR, Matafwali SK, Mwila C, Mudenda S, Katandula J, Walker RB. Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment. Molecules 2020;25:E5952. [PMID: 33339110 DOI: 10.3390/molecules25245952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
49 Ramírez-de-Arellano A, Gutiérrez-Franco J, Sierra-Diaz E, Pereira-Suárez AL. The role of estradiol in the immune response against COVID-19. Hormones (Athens) 2021. [PMID: 34142358 DOI: 10.1007/s42000-021-00300-7] [Reference Citation Analysis]
50 Alves HR, Lomba GSB, Gonçalves-de-albuquerque CF, Burth P. Irisin, Exercise, and COVID-19. Front Endocrinol 2022;13:879066. [DOI: 10.3389/fendo.2022.879066] [Reference Citation Analysis]
51 Džubera A, Chochol J, Illéš R, Chocholová A, Zemková E. Vertebral Algic Syndrome Treatment in Long COVID-Cases Reports. Int J Environ Res Public Health 2021;18:11457. [PMID: 34769973 DOI: 10.3390/ijerph182111457] [Reference Citation Analysis]